GGrantIndex
Sort

4,870 grants matching glp 1

The role of GLP-1 in normal and abnormal glucose tolerance

$322,966
David A. D'alessio · University Of Cincinnati · R01 · FY2013 · DK

Control of reproductive aging by germline stem cells

$322,875
Kerry Kornfeld · Washington University · R56 · FY2021 · AG

Large Animal (Dog) experimental support module

$322,859
Gustavo David Aguirre · University Of Pennsylvania · R24 · FY2015 · EY

A Randomized, placebo-controlled trial of the effects of Long-Acting GLP-1 or Dual Incretin (GLP-1 and GIP) Modulation on Gastrointestinal Functions and Relationship to Weight Loss

$322,800
Michael L Camilleri · Mayo Clinic Rochester · R01 · FY2025 · DK

Development of an Oral Pill to Mimic the Effects of Gastric Bypass Surgery

$322,787
Vasu Sethuraman · Syntis Bio Inc · R44 · FY2024 · DK

Discovery of biased small molecule agonists of the GLP-1 receptor for treatment o

$322,632
Johan Karl Enquist · Carmot Therapeutics, Inc. · R43 · FY2012 · DK

Human Rhodopsin-ADRP studies

$322,610
Artur V Cideciyan · University Of Pennsylvania · R24 · FY2012 · EY

Weight-Loss Diet Intervention on Cardiometabolic Factors of Gut Microbiota

$322,193
Lu Qi · Tulane University Of Louisiana · R01 · FY2017 · DK

Human Rhodopsin-ADRP studies

$322,079
Artur V Cideciyan · University Of Pennsylvania · R24 · FY2013 · EY

Brainstem Mechanisms of Stress Regulation

$322,054
James P Herman · University Of Cincinnati · R01 · FY2007 · MH

Clusterin Targeting Epitheliopathy for Dry Eye

$321,904
Kenneth J Mandell · Proteris Biotech, Inc. · R43 · FY2025 · EY

Brainstem Mechanisms of Stress Regulation

$321,782
James P Herman · University Of Cincinnati · R01 · FY2008 · MH

Protease Operated Depot for Delivery of GLP-1

$320,968
Ashutosh Chilkoti · Duke University · R01 · FY2013 · DK

Rodent pancreatic islet biology in health and disease

$320,904
David Harlan · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK

Pharmacokinetics and Subjective Responses to Alcohol After Bariatric Surgery

$320,708
Marta Yanina Pepino De Gruev · University Of Illinois At Urbana-Champaign · R01 · FY2017 · AA

Neurohumoral Regulation in Diabetic Enteropathy

$320,258
Mayo Clinic · P01 · FY2005 · DK

Development of cAMP Biosensor, High Content Imaging, and Functional GLP-1R aSSAYS

$320,235
Philip Lograsso · Scripps Research Institute, The · R01 · FY2007 · DK

Developing IpY: A novel inhibitor for the treatment of ER+ metastatic breast cancer

$320,217
Grace Chen · Concarlo Holdings, Llc · R43 · FY2020 · CA

Backbone-modified agonists of B-family GPCRs

$320,186
Samuel H. Gellman · University Of Wisconsin-Madison · R01 · FY2018 · GM

Personalized Nutrition Using Continuous Glucose Monitoring to Improve Outcomes in Type 2 Diabetes Mellitus

$319,990
Anne E Bantle · University Of Minnesota · R01 · FY2025 · DK

Treatment for cannabis use disorder

$319,898
Herbert H Seltzman · Artiam Bio Inc. · R43 · FY2022 · DA

CNS GLP-1 signaling in energy and glucose homeostasis

$319,800
Randy J. Seeley · University Of Cincinnati · R01 · FY2007 · DK

Large Animal (Dog) experimental support module

$319,674
Gustavo David Aguirre · University Of Pennsylvania · R24 · FY2016 · EY

Inpatient and outpatient infrastructure for T1DM clinical protocols

$319,614
David Harlan · Diabetes, Digestive, Kidney Diseases · Z01 · FY2007 · DK

Rodent pancreatic islet biology in health and disease

$319,614
David Harlan · Diabetes, Digestive, Kidney Diseases · Z01 · FY2007 · DK